\nSymbol: GOSS
\nDescription: They are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.
\nShares: 14.375 million
\nPrice Range: $16.00-$16.00
\nTrade Date: 2\/8
\nUnderwriter(s): BofA Merrill Lynch, Leerink, Barclays, Evercore ISI
\nTerms Added: 1-23-19<\/p>\n
Link to Prospectus<\/strong><\/a><\/p>\n Link to Retail Roadshow<\/strong><\/a><\/p>\n Business<\/strong>:\u00a0Their goal is to be an industry leader in each of these therapeutic areas (immunology, inflammation and oncology) and to enhance and extend the lives of patients suffering from such diseases. To accomplish this goal, they have assembled a deeply experienced and highly skilled group of industry veterans, scientists, clinicians and key opinion leaders from leading biotechnology and pharmaceutical companies, as well as leading academic centers from around the world. Their collective immunology and translational discovery and development expertise serves as the foundation of their company. They intend to maintain a scientifically rigorous and inclusive corporate culture where employees strive to bring improved therapeutic options to patients.<\/p>\n The following table highlights their preclinical and clinical programs.<\/em><\/p>\n IPO Boutiuqe Color, Commentary & Book-Building Status<\/strong>: The way the book comes together during the week of the roadshow is the most critical indicator to first-day and first-week performance. IPO Boutique uses its 45 years of experience and sources all over the street to gather daily subscription levels, specific price guidance and what type of investors are currently in the book or are anchoring orders in the book. In addition, recent underwriter performance on sector specific deals is a strong factor that IPO Boutique takes into account when determining if our clients should indicate for any offering.<\/p>\n IPO Boutique subscription clients receive daily updates on this critical information.<\/span><\/a><\/p>\n Conclusion<\/strong>: IPO Boutique provides ratings, daily commentary and a forecast for how this IPO will open vs. its offering price. We have kept a\u00a0track record<\/span><\/a>\u00a0with our performance for last 12 years at our website. Additionally, here’s a 2017 recap of our performance<\/a>\u00a0to showcase the value of IPO Boutique’s service.<\/p>\n![\"\"](\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/01\/Screen-Shot-2019-01-31-at-10.10.49-AM.png\")
<\/a><\/p>\n<\/a><\/p>\n